Vaginal Cuff Anesthesia and Post-Operative Pain Medication Use
A Prospective Randomized Controlled Trial of Vaginal Cuff Anesthesia and Post-Operative Pain Medication Use
MediSys Health Network
100 participants
Dec 1, 2024
INTERVENTIONAL
Conditions
Summary
The purpose of this study is to determine whether an injection of a local anesthetic (Bupivacaine with epinephrine) in the vaginal cuff prior to closure would result in less immediate postoperative pain medication and increase patient comfort/satisfaction.
Eligibility
Inclusion Criteria2
- Patients 18 years and older requiring total laparoscopic hysterectomy with or without bilateral salpingo-oophorectomy for benign conditions
- Presence of malignancy
Exclusion Criteria6
- Conversion to laparotomy
- Previous multiple abdominal and/or pelvic surgeries
- Significant medical comorbidities or cardiac history
- Poor initial Aldrete score4 (<10)
- Significant pre-op pain medication use
- Contraindication to any medication that would be used in the study (Bupivacaine, epinephrine, tramadol or oxycodone)
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Injection into the vaginal cuff will occur before vaginal cuff closure with stratafix suture. There will be four points of injection 1cm from the edges of the vaginal cuff with a sterilized needle to a depth of 3-4cm. 5cc of bupivacaine with epinephrine or 5cc of normal saline will be injected into each area
A saline placebo
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06719180